China Money Network
Login
Join

Hongtai Capital Backs Chinese Biopharma Firm Qyuns Therapeutics In Series B Round

  • July 31, 2019 — 18:00 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese biopharmaceutical firm Qyuns Therapeutics has raised several hundred millions of yuan in a series B round of financing led by Hongtai Capital, a venture... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: